Catalyst Wire Dossier Catalyst Wire Dossier

ZARXIO

FILGRASTIM-SNDZ · Sandoz Inc.
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for ZARXIO, covering 2015-03-06 to 2025-08-21. Get the full timeline:

Most recent: FDA Approved: ZARXIO — Supplemental Application (Sandoz Inc.)

See pricing